Medtronic, Inc. (NYSE:MDT), today announced approval by the U.S. Food and Drug Administration (FDA) of its new generation multi-exchange Zipper Stent Delivery Platform. This important
NEW YORK (Reuters Health) Oct 02 – Pulse-dye laser (PDL), intralesional steroids, and intralesional 5-fluorouracil (5-FU) appear to be equally effective treatments for keloidal and
By Alicia Ault WASHINGTON (Reuters Health) Oct 03 – A panel of US government advisers on Thursday called for more protections for people who participate
NEW YORK (Reuters Health) Oct 03 – In children with atopic dermatitis, the appearance of house dust mite (HDM)-specific immunoglobulin (Ig) E antibodies in early
By Will Boggs, MD NEW YORK (Reuters Health) Oct 04 – Major protocol deviations occur in two thirds of the cases of acute stroke thrombolytic
NEW YORK (Reuters Health) Oct 04 – Adipose tissue may be a determinant of transforming growth factor-beta-1 (TGF-beta-1) levels in hypertensive patients, perhaps mediated by
Laurie Barclay, MD Oct. 7, 2002 The benefits of angiotensin-converting enzyme (ACE) inhibitors outweigh any minor negative aspect of combining these drugs with aspirin,
Laurie Barclay, MD Oct. 7, 2002 Results from the Multiple Outcomes of Raloxifene (MORE) trial suggest that raloxifene is safe and effective in postmenopausal
By Will Boggs, MD NEW YORK (Reuters Health) Sept 30 – Active rheumatoid arthritis associated with elevated serum lipid levels improve significantly with the successful
Laurie Barclay, MD Oct. 1, 2002 In a multicenter, randomized trial reported in the Oct. 1 issue of Circulation, simvastatin was safe, effective, and
Laurie Barclay, MD Oct. 1, 2002 Sounding board articles in the Sept. 26 issue of the New England Journal of Medicine generated significant media
Patients on warfarin appear to have a significantly higher incidence of embolic events than heart failure patients not treated with warfarin. Researchers from St. Vincent’s
By Martha Kerr NEW YORK (Reuters Health) Sept 26 – Boston researchers report that through the use of infrared spectroscopy, they can differentiate between stable
Laurie Barclay, MD Sept. 27, 2002 Compared with stents, coronary artery bypass graft (CABG) reduced the rate of revascularization procedures in patients with coronary
Laurie Barclay, MD Sept. 27, 2002 Two studies presented on Sept. 26 at the American Heart Association 56th Annual High Blood Pressure Research Conference
Immune modulation therapy (IMT) appears to reduce death and hospitalization among patients with chronic heart failure. Dr. Guillermo Torre-Amione presented the results of the double-blind,
Carvedilol, alone or in combination with standard heart failure therapy, appears to reverse chemotherapy-induced congestive heart failure. Dr. Elizabeth Newsome and colleagues from the M.D.
Atorvastatin 80 mg/day lowered low-density lipoprotein (LDL) cholesterol levels further than did pravastatin 40 mg/day, and it also reversed atherosclerosis as reflected by reduced carotid
In a multicenter randomized trial reported in the Sept. 26 issue of the New England Journal of Medicine, warfarin or warfarin plus aspirin was better
Diabetic patients with chronic heart failure who were taking thiazolidinediones (TZD) developed refractory fluid retention, resulting in a presentation that researchers think may mimic heart